60 related articles for article (PubMed ID: 37350558)
1. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank.
Borgmästars E; Jacobson S; Simm M; Johansson M; Billing O; Lundin C; Nyström H; Öhlund D; Lubovac-Pilav Z; Jonsson P; Franklin O; Sund M
J Gastrointest Oncol; 2024 Apr; 15(2):755-767. PubMed ID: 38756646
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolite profiling identifies non-diabetic CP patients with metabolic alterations progressing to prediabetes prior to HbA1c.
Vijayasarathy K; Ramunaidu A; Ragi N; Pavankumar P; Simhadri V; Manne S; Krishnaiah S; Aslam M; Talukadar R; Devi CV; Rao GV; Amanchy R; Reddy DN; Sripadi P; Sasikala M
Clin Transl Gastroenterol; 2024 Apr; ():. PubMed ID: 38661171
[TBL] [Abstract][Full Text] [Related]
4. Postmortem metabolomics as a high-throughput cause-of-death screening tool for human death investigations.
Ward LJ; Kling S; Engvall G; Söderberg C; Kugelberg FC; Green H; Elmsjö A
iScience; 2024 May; 27(5):109794. PubMed ID: 38711455
[TBL] [Abstract][Full Text] [Related]
5. Straightforward Creation of Multishell Hollow Hybrids for an Integrated Metabolic Monitoring System in Disease Management.
Zhang M; Shi F; Chen Y; Yang C; Zhang X; Deng C; Sun N
Small; 2024 Mar; ():e2400941. PubMed ID: 38529737
[TBL] [Abstract][Full Text] [Related]
6. Development of a metabolite calculator for diagnosis of pancreatic cancer.
Choi M; Park M; Lee SH; Lee MJ; Paik YK; Jang SI; Lee DK; Lee SG; Kang CM
Cancer Med; 2023 Aug; 12(15):15933-15944. PubMed ID: 37350558
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
9. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
10. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis.
Machairas N; Raptis DA; Velázquez PS; Sauvanet A; Rueda de Leon A; Oba A; Koerkamp BG; Lovasik B; Chan C; Yeo CJ; Bassi C; Ferrone CR; Kooby D; Moskal D; Tamburrino D; Yoon DS; Barroso E; de Santibañes E; Kauffmann EF; Vigia E; Robin F; Casciani F; Burdío F; Belfiori G; Malleo G; Lavu H; Hartog H; Hwang HK; Han HS; Marques HP; Poves I; Domínguez-Rosado I; Park JS; Lillemoe KD; Roberts K; Sulpice L; Besselink MG; Abuawwad M; Del Chiaro M; de Santibañes M; Falconi M; D'Silva M; Silva M; Hilal MA; Qadan M; Sell NM; Beghdadi N; Napoli N; Busch ORC; Mazza O; Muiesan P; Müller PC; Ravikumar R; Schulick R; Powell-Brett S; Abbas SH; Mackay TM; Stoop TF; Gallagher TK; Boggi U; van Eijck C; Clavien PA; Conlon KCP; Fusai GK
Ann Surg; 2021 Nov; 274(5):721-728. PubMed ID: 34353988
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics in cancer research and emerging applications in clinical oncology.
Schmidt DR; Patel R; Kirsch DG; Lewis CA; Vander Heiden MG; Locasale JW
CA Cancer J Clin; 2021 Jul; 71(4):333-358. PubMed ID: 33982817
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
